Quick Summary
Erectile dysfunction and low testosterone frequently coexist but are driven by different mechanisms. ED is primarily a vascular condition, while low testosterone is a systemic hormonal deficiency. Treating only the symptom (ED) without investigating the underlying cause (potentially low T) often leads to incomplete results. A comprehensive diagnostic approach that evaluates both vascular and hormonal health leads to significantly better outcomes.
Two Conditions, One Conversation
When a man begins experiencing difficulties in the bedroom, the instinct is often to lump everything under the umbrella of "erectile dysfunction." A visit to the doctor, a prescription for a blue pill, and the assumption that the problem is solved. But for a significant number of men, particularly those over 40, the real picture is considerably more nuanced. What looks like straightforward ED may actually be a symptom of a deeper hormonal problem. And what appears to be low testosterone may coexist with genuine vascular dysfunction. Understanding the distinction between these two conditions, and where they overlap, is critical for getting the right treatment.
The numbers tell a compelling story. Erectile dysfunction affects an estimated 52% of men between ages 40 and 70, according to the Massachusetts Male Aging Study. Meanwhile, testosterone deficiency affects approximately 30% of men aged 40 to 79. There is substantial overlap between these populations. Research published in PMC examining the relationship between testosterone and erectile dysfunction found that more than 20% of men presenting with sexual dysfunction had low testosterone levels. Yet in routine clinical practice, many men with ED never have their testosterone levels checked.
This diagnostic gap matters because the treatment for vascular ED and the treatment for hormonal deficiency are fundamentally different. Addressing only one without evaluating for the other frequently leads to frustration, incomplete improvement, and the sense that nothing works. At Man UnPaused, we believe every man experiencing sexual health changes deserves a complete picture of what is happening inside his body.
How Erections Actually Work: A Brief Primer
To understand where things can go wrong, it helps to understand the mechanics of a normal erection. The process begins in the brain when sexual stimulation, whether visual, physical, or psychological, triggers the release of neurotransmitters along the nerve pathways leading to the penis. These signals cause the smooth muscle cells lining the penile arteries to relax, allowing blood to rush into the spongy erectile chambers called the corpora cavernosa. As these chambers fill, they compress the veins that normally drain blood away, trapping the blood and producing rigidity.
The key chemical messenger in this process is nitric oxide (NO). Released by the endothelial cells lining the penile arteries, nitric oxide triggers a cascade that ultimately relaxes smooth muscle and allows blood flow. This is where testosterone enters the picture. Testosterone stimulates the production of nitric oxide synthase, the enzyme responsible for generating nitric oxide. It also maintains the health and responsiveness of the smooth muscle tissue itself. Without adequate testosterone, the entire vascular mechanism of erection becomes less efficient, even if the blood vessels themselves are structurally healthy.
This is the critical intersection where ED and low testosterone meet. The erection depends on both healthy vasculature and adequate hormonal support. Problems in either system can produce similar symptoms, but the solutions are different.
Vascular ED vs. Hormonal ED: Key Differences
While both types of ED can produce similar difficulties with erections, they present differently in important ways that can guide diagnosis and treatment.
Vascular erectile dysfunction is primarily a plumbing problem. The blood vessels supplying the penis are damaged, narrowed, or less responsive, preventing adequate blood flow for a firm erection. This type of ED is strongly associated with cardiovascular risk factors including hypertension, diabetes, high cholesterol, smoking, and obesity. Men with vascular ED often still have sexual desire and can become mentally aroused, but the physical response does not follow. Morning erections may be reduced or absent. Vascular ED can develop relatively suddenly compared to hormonal causes, and it is often an early warning sign of broader cardiovascular disease. In fact, ED has been called the "canary in the coal mine" for heart disease, with studies showing it can precede a cardiovascular event by 3 to 5 years.
Hormonal erectile dysfunction is driven by insufficient testosterone. It typically develops gradually over months or years as testosterone levels progressively decline. The hallmark difference is that hormonal ED is almost always accompanied by decreased libido. Men with hormonally driven erectile difficulties often report that they simply do not feel the desire for sex the way they used to, and that erection problems are secondary to the loss of drive. Other testosterone deficiency symptoms are commonly present, including persistent fatigue, increased abdominal fat, difficulty concentrating, irritability, and reduced muscle mass.
In clinical practice, many men have elements of both. A man with gradually declining testosterone may simultaneously be developing early vascular changes from metabolic syndrome. Low testosterone itself increases cardiovascular risk factors. This is why a thorough evaluation of both hormonal and vascular health is essential for any man experiencing erectile difficulties after 40.
The Diagnostic Pathway: Getting Answers
A proper diagnostic workup for erectile dysfunction should include both hormonal and vascular assessment. Unfortunately, many men receive a prescription for PDE5 inhibitors after a brief conversation without any bloodwork at all. While this approach may provide temporary symptomatic relief, it misses potentially important underlying causes.
Hormonal evaluation should include, at minimum, total testosterone, free testosterone, SHBG (sex hormone-binding globulin), estradiol, LH (luteinizing hormone), and a complete metabolic panel. A high LH level paired with low testosterone suggests primary testicular failure, meaning the testes themselves are underproducing. A low LH level paired with low testosterone points to a central deficiency originating in the pituitary gland or hypothalamus. This distinction matters because it influences treatment selection. The evaluation should be done with a morning blood draw, as testosterone levels peak in the early morning and can be significantly lower later in the day.
Vascular assessment involves evaluating cardiovascular risk factors including blood pressure, fasting glucose, hemoglobin A1c, and lipid panel. For men where vascular causes are suspected, duplex ultrasonography of the penile arteries can provide direct measurement of blood flow. In this procedure, blood flow is measured before and after injection of a vasodilator. A peak systolic velocity lower than 25 cm/sec is generally accepted as indicating arterial insufficiency.
At Man UnPaused, our free screening quiz is designed to help identify which factors may be contributing to your symptoms. Our board-certified specialists then order comprehensive lab panels that evaluate both hormonal and metabolic markers, providing the complete diagnostic picture needed for effective treatment.
Why Treating Underlying Hormone Issues Matters
There is a temptation in modern medicine to treat symptoms rather than causes. A man presents with ED, receives a PDE5 inhibitor, and the immediate problem appears solved. But if the underlying cause is testosterone deficiency, this approach falls short in multiple ways.
First, PDE5 inhibitors enhance blood flow but do nothing for sexual desire. If a man has hormonal low libido alongside his erectile difficulties, Viagra will help him achieve an erection but will not restore the desire that makes intimacy feel natural and spontaneous. Many men on PDE5 inhibitors alone describe sex as mechanically functional but emotionally hollow, precisely because the hormonal drive is missing.
Second, untreated testosterone deficiency continues to affect every other system in the body. Fatigue persists. Body composition deteriorates. Mood and cognitive function decline. Bone density decreases. Cardiovascular risk may increase. By focusing solely on erectile function while ignoring the systemic hormonal deficit, a significant portion of the clinical picture goes unaddressed.
Third, and critically for men frustrated by partial results, testosterone deficiency can make PDE5 inhibitors less effective. Research published in European Urology has demonstrated that men with ED and low testosterone who fail to respond adequately to PDE5 inhibitors can see improved clinical response when testosterone therapy is added. A systematic review and meta-analysis published in Translational Andrology and Urology confirmed that combination therapy of testosterone plus PDE5 inhibitors was superior to PDE5 inhibitors alone in men with both conditions, with a pooled effect size that was statistically significant.
PDE5 Inhibitors vs. TRT: When to Use What
Understanding when each treatment is appropriate requires understanding what each one does.
PDE5 inhibitors (sildenafil, tadalafil, vardenafil) work by blocking the enzyme phosphodiesterase type 5, which breaks down cyclic GMP, the molecule responsible for smooth muscle relaxation in the penis. By inhibiting this enzyme, PDE5 inhibitors prolong and enhance the blood flow response that creates an erection. They work on demand, typically within 30 to 60 minutes, and are effective for the majority of men with vascular ED. They do not affect testosterone levels, sexual desire, or any other systemic hormone-related symptoms.
Testosterone replacement therapy addresses the hormonal deficit systemically. It restores testosterone to optimal levels, which improves libido, supports nitric oxide production, maintains penile tissue health, and addresses the full spectrum of testosterone deficiency symptoms including energy, mood, body composition, and cognitive function. However, TRT takes time. Improvements in libido typically appear within 3 to 6 weeks, but full effects on erectile function may require 3 to 6 months as tissue health and vascular responsiveness improve.
The evidence increasingly supports a combined approach for men with both conditions. The TRAVERSE trial, one of the largest and most recent testosterone therapy trials, found that testosterone therapy improved sexual activity and libido among men with low testosterone, while the addition of PDE5 inhibitors addressed the vascular component of erectile function. Findings from European Urology confirm that combining testosterone therapy with PDE5 inhibitors produced better results than either treatment alone, particularly in men who had previously not responded to PDE5 inhibitors on their own.
At Man UnPaused, our treatment programs are built around this comprehensive philosophy. We do not simply prescribe one medication and hope for the best. We evaluate the complete hormonal and metabolic picture, identify every contributing factor, and build a treatment protocol tailored to each individual patient. For some men, TRT alone is sufficient. For others, a combination approach produces the best results. The key is knowing which approach is right for you, and that requires proper testing.
Taking the Right First Step
If you are dealing with erectile difficulties, decreased desire, or both, the most important thing you can do is get a complete evaluation rather than settling for a one-size-fits-all solution. A PDE5 inhibitor prescription without bloodwork is like treating a cough without listening to the lungs. It may help temporarily, but it misses the diagnosis.
Start by asking yourself these questions:
- Has your interest in sex declined along with your erectile function?
- Are you experiencing other symptoms like fatigue, weight gain, or mood changes?
- Have PDE5 inhibitors worked partially but not fully?
- Has anyone tested your testosterone, free testosterone, and SHBG levels?
- Have your morning erections become less frequent or disappeared?
If you answered yes to two or more of these questions, there is a meaningful probability that hormonal factors are contributing to your erectile difficulties. Our free 3-minute screening quiz can help you assess your symptom profile confidentially. If the results suggest hormonal involvement, our board-certified specialists can guide you through comprehensive testing and develop a treatment plan that addresses the actual causes, not just the symptoms.
ED and low testosterone are both treatable conditions. But treating them effectively requires understanding which one you have, whether you have both, and what the best approach is for your specific situation. That understanding starts with a conversation and a blood test. Everything else follows from there.